Home Two Innovative Cardiac Ablation Devices Receive NMPA Approval for Drug-Refractory Paroxysmal Atrial Fibrillation

Two Innovative Cardiac Ablation Devices Receive NMPA Approval for Drug-Refractory Paroxysmal Atrial Fibrillation

Mar 31, 2026 17:40 CST Updated 17:40
Synaptic Medical

Cardiovascular Medical Device R&D Developer

图片

Recently, the National Medical Products Administration approved the registration application for the cryoablation system and the disposable balloon-type cryoablation catheter from Synaptic Medical Technology (Beijing) Co., Ltd.

The cryoablation system consists of a cryoablation system main unit and a touch screen. The single-use balloon-type cryoablation catheter is composed of a balloon-type cryoablation catheter, a coaxial fluid connector tube, and a connecting cable. The cryoablation system is used in conjunction with the single-use balloon-type cryoablation catheter for the treatment of adult patients with drug-refractory, recurrent, symptomatic paroxysmal atrial fibrillation.


This product uses a compliant, adjustable-diameter balloon, which is a first in China, and is expected to improve the success rate of pulmonary vein occlusion.


Recommended Reading

National Medical Products Administration Launches "Spring Rain Action" for Clinical Innovation and Transformation


Pre-Review of Clinical Trial Protocols for Innovative Products


Eight Medical Devices Enter Innovation Publicity


Two Common Issues in Registration Review

Image